Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53

被引:0
|
作者
Lisa S St. John
Edward R Sauter
Meenhard Herlyn
Samuel Litwin
Karen Adler-Storthz
机构
[1] Dental Branch,Department of Basic Sciences
[2] Graduate School of Biomedical Sciences,Department of Biostatistics
[3] University of Texas-Houston Health Science Center,undefined
[4] The Wistar Institute,undefined
[5] Fox Chase Cancer Center,undefined
来源
Cancer Gene Therapy | 2000年 / 7卷
关键词
p53; squamous cell carcinoma; growth arrest; apoptosis; WAF1; WAF1; p21.;
D O I
暂无
中图分类号
学科分类号
摘要
Prior reports suggest that p53 protein status may influence the response to gene transduction with wild-type (wt) p53. Adenoviral vectors containing the p53 gene were administered to normal keratinocytes, to squamous cell carcinoma (SCC) lines with varied p53 protein status (absent, mutant, wt, or degraded by papillomavirus), as well as to tumors formed in severe combined immunodeficient mice. The percentage of cells undergoing apoptosis, G1 growth arrest, WAF1/p21 induction, and in vivo tumor progression were studied after wt p53 gene transduction. Apoptosis developed first in normal keratinocytes, next in SCCs lacking p53 protein, and last in SCCs with mutant or degraded p53 protein. All of the cell lines studied demonstrated an increase in WAF1/p21 protein, but only those lacking p53 protein showed G1 arrest. Tumors lacking p53 protein were more susceptible to p53 overexpression than those containing mutant or degraded p53 protein. The endogenous p53 protein status of SCCs appears to influence the outcome of p53 gene transduction.
引用
收藏
页码:749 / 756
页数:7
相关论文
共 50 条
  • [41] p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan
    Hsieh, LL
    Huang, TH
    Chen, IH
    Liao, CT
    Wang, HM
    Lai, CH
    Liou, SH
    Chang, JTC
    Cheng, AJ
    BRITISH JOURNAL OF CANCER, 2005, 92 (01) : 30 - 35
  • [42] Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation
    Venkatachalam, S
    Shi, YP
    Jones, SN
    Vogel, H
    Bradley, A
    Pinkel, D
    Donehower, LA
    EMBO JOURNAL, 1998, 17 (16) : 4657 - 4667
  • [43] Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas
    Song, KM
    Li, ZW
    Seth, P
    Cowan, KH
    Sinha, BK
    ONCOLOGY RESEARCH, 1997, 9 (11-12) : 603 - 609
  • [44] Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway
    Asra Mirza
    Marnie McGuirk
    Tish N Hockenberry
    Qun Wu
    Hena Ashar
    Stuart Black
    Shu Fen Wen
    Luquan Wang
    Paul Kirschmeier
    W Robert Bishop
    Loretta L Nielsen
    Cecil B Pickett
    Suxing Liu
    Oncogene, 2002, 21 : 2613 - 2622
  • [45] Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway
    Mirza, A
    McGuirk, M
    Hockenberry, TN
    Wu, Q
    Ashar, H
    Black, S
    Wen, SF
    Wang, LQ
    Kirschmeier, P
    Bishop, WR
    Nielsen, LL
    Pickett, CB
    Liu, SX
    ONCOGENE, 2002, 21 (17) : 2613 - 2622
  • [46] Ginkgo Biflavones Cause p53 Wild-Type Dependent Cell Death in a Transcription-Independent Manner of p53
    Zhang, Siyu
    Sun, Yujie
    Yao, Fengli
    Li, Hongju
    Yang, Yacong
    Li, Xionghao
    Bai, Zhongyue
    Hu, Yu
    Wang, Peng
    Xu, Ximing
    JOURNAL OF NATURAL PRODUCTS, 2023, 86 (02): : 346 - 356
  • [47] ADP-ribosylation of p53 tumor suppressor protein: Mutant but not wild-type p53 is modified
    WesierskaGadek, J
    BugajskaSchretter, A
    Cerni, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, 62 (01) : 90 - 101
  • [48] Chaperoning of Mutant p53 Protein by Wild-type p53 Protein Causes Hypoxic Tumor Regression
    Gogna, Rajan
    Madan, Esha
    Kuppusamy, Periannan
    Pati, Uttam
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (04) : 2907 - 2914
  • [49] P53 GENE STATUS IN ENDOMETRIAL CARCINOMAS SHOWING DIFFUSE POSITIVITY FOR P53 PROTEIN BY IMMUNOHISTOCHEMICAL ANALYSIS
    AMBROS, RA
    ROSS, JS
    KALLAKURY, BVS
    MALFETANO, J
    KIM, YR
    HWANG, J
    BREESE, K
    FIGGE, J
    MODERN PATHOLOGY, 1995, 8 (04) : 441 - 445
  • [50] Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53
    Sugikawa, E
    Yazaki, N
    Tsunoda, S
    Nakanishi, N
    Ohashi, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) : 256 - 263